Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Esophageal injection sclerosis.

S A McClave

    International Journal of Dermatology
    |May 1, 1987
    PubMed
    Summary
    This summary is machine-generated.

    Esophageal injection sclerosis (EIS) effectively manages bleeding from esophageal varices, a complication of cirrhosis. This treatment offers high success rates for acute bleeding control and long-term variceal obliteration, improving patient outcomes.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Guidelines for nutrition therapy in critical illness: are not they all the same?

    Minerva anestesiologica·2011
    Same author

    Should indirect calorimetry be used as part of nutritional assessment?

    Journal of clinical gastroenterology·2001
    Same author

    The effects of immune-enhancing diets (IEDs) on mortality, hospital length of stay, duration of mechanical ventilation, and other parameters.

    JPEN. Journal of parenteral and enteral nutrition·2001
    Same author

    Dissecting the energy needs of the body.

    Current opinion in clinical nutrition and metabolic care·2001
    Same author

    Postal consent for upper gastrointestinal endoscopy.

    Gastrointestinal endoscopy·2001
    Same author

    Defining tolerance to enteral feeding in the intensive care unit.

    Clinical nutrition (Edinburgh, Scotland)·2000
    Same journal

    Immune Checkpoint Inhibitors are Associated With Increased Risk of Lichen Planus in a TriNetX Analysis.

    International journal of dermatology·2026
    Same journal

    Long Distance Non-Contact Dermoscopy: Technological Foundations, Clinical Applications, and Future Directions.

    International journal of dermatology·2026
    Same journal

    Ulceronecrotic Plaques, Patchy Scalp Alopecia and Visual Disturbance in a 46-Year-Old Man.

    International journal of dermatology·2026
    Same journal

    Beyond 1993: A Case Illustrating the 2021 Revised Criteria for Paraneoplastic Autoimmune Multiorgan Syndrome.

    International journal of dermatology·2026
    Same journal

    Association Between pTERT Promoter Mutation Subtypes and Survival Outcomes in BRAF-Mutant Metastatic Melanoma Treated With BRAF/MEK Inhibitors: An Exploratory Study.

    International journal of dermatology·2026
    Same journal

    Updated Vitiligo Trends in the Burden of Psychiatric and Autoimmune Diseases.

    International journal of dermatology·2026
    See all related articles

    Area of Science:

    • Gastroenterology
    • Hepatology
    • Interventional Endoscopy

    Background:

    • Esophageal varices, a complication of portal hypertension and cirrhosis, present a significant risk of life-threatening hemorrhage.
    • Hemorrhage from esophageal varices has high mortality (50-60%) and re-bleeding rates (40-60%).

    Purpose of the Study:

    • To evaluate the efficacy and safety of Esophageal Injection Sclerosis (EIS) for managing acute and chronic esophageal variceal hemorrhage.
    • To compare EIS with existing therapies like surgical portacaval shunt and medical management.

    Main Methods:

    • Esophageal injection sclerosis (EIS) involves injecting a sclerosing agent into esophageal varices.
    • Therapeutic decisions involve agent choice, volume, concentration, injection intervals, and patterns.

    Related Experiment Videos

    Main Results:

    • EIS achieves acute bleeding control in 85-95% of cases.
    • Long-term obliteration of varices is achieved in 60-80% of patients treated with EIS.
    • EIS reduces hospitalization time, blood transfusion requirements, and potentially prolongs survival.

    Conclusions:

    • Esophageal injection sclerosis is an effective and safe treatment for acute and long-term management of esophageal variceal hemorrhage.
    • EIS is a preferred therapy, superior to surgical shunts and medical treatments in most aspects.
    • Complications can be minimized through careful management of the sclerosing agent and injection technique.